Reference-scaled Bioequivalence Documentation

Reference-Scaled Bioequivalence Documentation is a regulatory documentation framework that, as a genus, belongs to the class of bioequivalence assessment protocols, and, by differentia, is distinguished by its incorporation of scaled bioequivalence criteria wherein the acceptance limits for average bioequivalence are dynamically adjusted based on the within-subject variability of the reference product.

2

Publications

39

Citations

7

Authors

5

Institutions

Publications per year

2017–2026

1

Authors

7

  1. YZ
    Yifan Zhang

    Shanghai Institute of Materia Medica, China

    1 publications · 14 citations

    1

    h-index

  2. LE
    László Endrényi

    University of Toronto, Canada

    1 publications · 25 citations

    1

    h-index

  3. YL
    Youming Lu

    Shenzhen University, China

    1 publications · 14 citations

    1

    h-index

  4. DZ
    Dafang Zhong

    Shanghai Institute of Materia Medica, China

    1 publications · 14 citations

    1

    h-index

  5. YT
    Yunbiao Tang

    Jilin University, China

    1 publications · 14 citations

    1

    h-index

1–5 of 7

Venues

  1. Drug Design Development and Therapy

    1 publications · 14 citations

    1

    h-index

  2. The AAPS Journal

    AAPSJ · 1 publications · 25 citations

    1

    h-index

  3. International Journal of Pharmaceutics

    1 publications · 13 citations

1–3